TITLE

Study casts doubt on obesity theory

PUB. DATE

February 1996

SOURCE

Indianapolis Business Journal;2/5/96, Vol. 16 Issue 47, p14A

SOURCE TYPE

Periodical

DOC. TYPE

Article

ABSTRACT

Reports that a study conducted by researchers at Eli Lilly & Co. has challenged the genetic theories on obesity. Findings on the level of the protein leptin in obese persons; Licensing of the rights to the obesity protein; Competition for drugs to combat obesity.

ACCESSION #

9602191109

Tags: OBESITY;  ELI Lilly & Co.

 

Related Articles

• Pills to Get Fido Slim and Sane. Gaudio, Thomas // njbiz;3/12/2007, Vol. 20 Issue 11, p3 

  The article looks at the growing trend in the medical sector in which drug companies are committing themselves in developing drugs that would improve pet health. Pfizer and Novartis are focusing more on treating anxiety and canine obesity. Peter Falk, veterinarian and co-owner of Ocean County...

• Even Without Prozac, Lilly Won't Suffer Depression. Seiden, Carl // Medical Marketing & Media;Mar2002, Vol. 37 Issue 3, p62 

  Focuses on the improvement of sales and marketing capabilities of Prozac from Eli Lillys & Co. Prescription volume of Prozac; Products offered by company; Estimation of the earnings of Eli. INSET: LILLY'S LAUNCHES: THIS YEAR'S PROSPECTS.

• Lilly deals its Rx discount card.  // Medical Marketing & Media;Apr2002, Vol. 37 Issue 4, p22 

  Reports on the offer of the drug discount program for the aged by Eli Lilly & Co. in the U.S. Effectivity of the program; Total number of aged eligible for coverage; Benefits of the program.

• Eli Lilly and Company's disease state management and managed pharmaceuticals program. Sipkoff, Martin; Oss, Monica E. // Behavioral Health Management;Nov/Dec95, Vol. 15 Issue 6, p28 

  Profiles Eli Lilly and Company, a drug company. Business history; Services offered; Care targets.

• Steam accidents injure workers.  // Contractor Magazine;Nov2002, Vol. 49 Issue 11, p14 

  Reports on the investigation of an explosion on October 10, 2002 that injured two people at an Eli Lilly Co. plant in Greenfield, Indiana by the Indiana Occupational Safety and Health Administration. Description of the explosion; Condition of the injured workers.

• Eli Lilly exploring new marketing opportunities.  // Drug Store News;12/14/98, Vol. 20 Issue 20, pCP22 

  Reports on Eli Lilly & Co.'s plan to explore new indications and market opportunities for several of its major drugs. Sales of the company's schizophrenia drug, Zyprexa, in 1996.

• Lilly Digest will not be published this year.  // Drug Topics;9/6/93, Vol. 137 Issue 17, p6 

  Reveals that Eli Lilly & Co.'s `Lilly Digest' publication will not be published in 1993. Substitute individual analysis for independent pharmacists that supplied financial data; Possible termination of Lilly Digest.

• Lilly halts HIV research, but not AIDS-related work. Rodgers, Katie // Drug Topics;2/7/94, Vol. 138 Issue 3, p33 

  Reports on the plans of Eli Lilly & Co. for drug research. Discontinuation of research on HIV; Continued research on the AIDS drug LY30046; Development of anti-infectives; Cancer research; Therapeutic categories for drug development.

• Born-Again Prozac: Not Worth the Extra Cost. Napoli, Maryann // HealthFacts;Jul2001, Vol. 26 Issue 7, p1 

  Announces the move of Eli Lilly company to release a repackaged version and a new dosage form of its antidepressant drug Prozac in the United States.

Read the Article